Behrad Gen Pharmed

Behrad Gen Pharmed is a prominent Iranian biotechnology company focused on the development and manufacturing of high-quality biopharmaceuticals. Founded in 2013, the company specializes in the production of biosimilars, including monoclonal antibodies and recombinant proteins. Their therapeutic focus spans oncology, hematology, immunology, and endocrinology, addressing significant healthcare needs in the region. The company operates advanced manufacturing facilities in the Alborz Pharmaceutical Industrial Park, which are designed to meet international GMP standards. Behrad Gen Pharmed's portfolio includes biosimilar versions of widely used biologics such as rituximab, trastuzumab, and somatropin. By providing locally manufactured biological therapies, the company enhances patient access to life-saving treatments while reducing healthcare costs. They are committed to expanding their research and development capabilities to introduce new therapeutic options to the Middle Eastern market.